跳至主要内容
临床试验/NCT05371600
NCT05371600已完成4 期

The Effect of Preoperative Anxiolysis With Intravenous Midazolam on Intraoperative Sevoflurane Gas Consumption: A Prospective Randomized Controlled Study

Cukurova University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年12月2日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
80
试验地点
1
主要终点
Sevoflurane consumption

研究概览

简要总结

This prospective, randomized, double-blind, placebo-controlled study is performed after obtaining written informed consent of patients who are scheduled for elective general surgery. After the admission to the preoperative unit 30 minutes before the surgery, The preoperative anxiety of patients is evaluated by The State-Trait Anxiety Inventory (STAI). Patients are randomly assigned to one of two groups in a 1:1 ratio by a computer-generated list. Patients receive midazolam IV at 0.04 mg/kg (group M) and an equal volume of saline IV (group C, control group). Anesthesia is induced with 2mg/kg of IV propofol. At a dose of 0.6 mg/kg, IV rocuronium bromide is given for neuromuscular blockade. Anesthesia is maintained at 2% sevoflurane. At the end of the surgery, anesthesia is terminated and the awake patients are extubated.

详细描述

An equal depth of anesthesia is achieved by evaluating an entropy value of 40-50 during the operation. Heart rate, blood pressure, the amount of sevoflurane consumed (ml), end-tidal sevoflurane concentration (%), sevoflurane MAC, inspiratory sevoflurane (%) are recorded at baseline and 15-minute intervals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists physical status 1 and 2
  • patients who are scheduled for elective surgery

排除标准

  • history of psychiatric disease
  • use of psychotropic medications
  • neurological disorders
  • chronic pain
  • cardiovascular, respiratory, and hepatic diseases.

研究组 & 干预措施

Group M

Active Comparator

Patients receive midazolam IV at 0.04 mg/kg (group M).

干预措施: Midazolam (Drug)

Group C

Placebo Comparator

Patients receive an equal volume of saline IV (group C, control group).

干预措施: Saline (Other)

结局指标

主要结局

Sevoflurane consumption

时间窗: 1 hour

The amount of sevoflurane consumed (ml)

次要结局

  • end-tidal sevoflurane concentration (%)(1 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ersel GULEC

Principal Investigator

Cukurova University

研究点 (1)

Loading locations...

相似试验